UPDATE: Kura Oncology (KURA) Tops Q1 EPS by 1c; Expands Enrollment in Phase 2 Trial of Tipifarnib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to UPDATE: Kura Oncology (KURA) Tops Q1 EPS by 1c; Expands Enrollment in Phase 2 Trial of Tipifarnib
(NASDAQ: KURA) Delayed: 11.73 +0.01 (0.09%)
Previous Close $11.72    52 Week High $8.90 
Open $11.64    52 Week Low $2.50 
Day High $11.84    P/E N/A 
Day Low $11.56    EPS $0.00 
Volume 2,665,263